Advertisement
Screener

Crinetics Pharmaceuticals, Inc. (CRNX) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Crinetics Pharmaceuticals, Inc. Operating Cash Flow

Crinetics Pharmaceuticals, Inc. (CRNX) reported Operating Cash Flow of -$218.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-03

  • Crinetics Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$94.19M.
  • Crinetics Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$124.70M.
  • Crinetics Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$92.90M.
  • Crinetics Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$110.72M.
  • Crinetics Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$377.92M.
  • Crinetics Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$230.19M.
  • Crinetics Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$168.60M.
  • Crinetics Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$115.20M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$94.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03
-$218.90M
10-Q · filed 2026-08-03
-$311.80M
derived: sum of 3 quarters · filed 2026-08-03
-$422.51M
derived: sum of 4 quarters · filed 2026-08-03
2026-03-31-$124.70M
10-Q · filed 2026-05-07
-$217.60M
derived: sum of 2 quarters · filed 2026-05-07
-$328.32M
derived: sum of 3 quarters · filed 2026-05-07
-$414.17M
derived: sum of 4 quarters · filed 2026-08-03
2025-12-31-$92.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$203.62M
derived: sum of 2 quarters · filed 2026-02-26
-$289.47M
derived: sum of 3 quarters · filed 2026-08-03
-$377.92M
10-K · filed 2026-02-26
2025-09-30-$110.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$196.57M
derived: sum of 2 quarters · filed 2026-08-03
-$285.02M
10-Q · filed 2025-11-06
-$351.89M
derived: sum of 4 quarters · filed 2026-08-03
2025-06-30-$85.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03
-$174.30M
10-Q · filed 2026-08-03
-$241.17M
derived: sum of 3 quarters · filed 2026-08-03
-$304.00M
derived: sum of 4 quarters · filed 2026-08-03
2025-03-31-$88.45M
10-Q · filed 2026-05-07
-$155.32M
derived: sum of 2 quarters · filed 2026-05-07
-$218.15M
derived: sum of 3 quarters · filed 2026-05-07
-$265.79M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$66.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$129.69M
derived: sum of 2 quarters · filed 2026-02-26
-$177.34M
derived: sum of 3 quarters · filed 2026-02-26
-$230.19M
10-K · filed 2026-02-26
-$225.97M
10-K · filed 2025-02-27
2024-09-30-$62.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$110.47M
derived: sum of 2 quarters · filed 2025-11-06
-$163.32M
10-Q · filed 2025-11-06
-$161.30M
10-Q · filed 2024-11-12
-$204.13M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$47.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$100.50M
10-Q · filed 2025-08-07
-$98.47M
10-Q · filed 2024-08-08
-$141.31M
derived: sum of 3 quarters · filed 2026-02-26
-$182.65M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$52.86M
10-Q · filed 2025-05-08
-$93.66M
derived: sum of 2 quarters · filed 2026-02-26
-$135.00M
derived: sum of 3 quarters · filed 2026-02-26
-$180.74M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$40.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$82.14M
derived: sum of 2 quarters · filed 2026-02-26
-$127.88M
derived: sum of 3 quarters · filed 2026-02-26
-$168.60M
10-K · filed 2026-02-26
-$166.31M
10-K · filed 2024-02-28
2023-09-30-$41.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$87.07M
derived: sum of 2 quarters · filed 2024-11-12
-$127.79M
10-Q · filed 2024-11-12
-$163.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$45.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$86.45M
10-Q · filed 2024-08-08
-$121.66M
derived: sum of 3 quarters · filed 2025-02-27
-$160.14M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$40.72M
10-Q · filed 2024-05-09
-$75.92M
derived: sum of 2 quarters · filed 2025-02-27
-$114.40M
derived: sum of 3 quarters · filed 2025-02-27
-$142.38M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$35.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$73.69M
derived: sum of 2 quarters · filed 2025-02-27
-$101.66M
derived: sum of 3 quarters · filed 2025-02-27
-$115.20M
10-K · filed 2025-02-27
2022-09-30-$38.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$66.45M
derived: sum of 2 quarters · filed 2023-11-07
-$80.00M
10-Q · filed 2023-11-07
-$102.90M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$27.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$41.52M
10-Q · filed 2023-08-08
-$64.42M
derived: sum of 3 quarters · filed 2024-02-28
-$90.09M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$13.54M
10-Q · filed 2023-05-09
-$36.44M
derived: sum of 2 quarters · filed 2024-02-28
-$62.12M
derived: sum of 3 quarters · filed 2024-02-28
-$82.06M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$22.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$48.57M
derived: sum of 2 quarters · filed 2024-02-28
-$68.52M
derived: sum of 3 quarters · filed 2024-02-28
-$88.59M
10-K · filed 2024-02-28
2021-09-30-$25.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$45.62M
derived: sum of 2 quarters · filed 2022-11-14
-$65.69M
10-Q · filed 2022-11-14
-$81.63M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$19.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$40.02M
10-Q · filed 2022-08-12
-$55.95M
derived: sum of 3 quarters · filed 2023-02-28
-$73.96M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$20.07M
10-Q · filed 2022-05-12
-$36.01M
derived: sum of 2 quarters · filed 2023-02-28
-$54.01M
derived: sum of 3 quarters · filed 2023-02-28
-$69.86M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$15.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$33.94M
derived: sum of 2 quarters · filed 2023-02-28
-$49.80M
derived: sum of 3 quarters · filed 2023-02-28
-$62.03M
10-K · filed 2023-02-28
2020-09-30-$18.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$33.86M
derived: sum of 2 quarters · filed 2021-11-05
-$46.09M
10-Q · filed 2021-11-05
-$59.54M
derived: sum of 4 quarters · filed 2022-03-30
2020-06-30-$15.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
-$28.09M
10-Q · filed 2021-08-10
-$41.53M
derived: sum of 3 quarters · filed 2022-03-30
-$55.14M
derived: sum of 4 quarters · filed 2022-03-30
2020-03-31-$12.23M
10-Q · filed 2021-05-06
-$25.68M
derived: sum of 2 quarters · filed 2022-03-30
-$39.28M
derived: sum of 3 quarters · filed 2022-03-30
-$51.85M
derived: sum of 4 quarters · filed 2022-03-30
2019-12-31-$13.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$27.05M
derived: sum of 2 quarters · filed 2022-03-30
-$39.62M
derived: sum of 3 quarters · filed 2022-03-30
-$46.38M
10-K · filed 2022-03-30
2019-09-30-$13.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$26.18M
derived: sum of 2 quarters · filed 2020-11-06
-$32.93M
10-Q · filed 2020-11-06
-$38.94M
derived: sum of 4 quarters · filed 2021-03-30
2019-06-30-$12.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$19.33M
10-Q · filed 2020-08-07
-$25.34M
derived: sum of 3 quarters · filed 2021-03-30
-$31.03M
derived: sum of 4 quarters · filed 2021-03-30
2019-03-31-$6.76M
10-Q · filed 2020-05-08
-$12.77M
derived: sum of 2 quarters · filed 2021-03-30
-$18.46M
derived: sum of 3 quarters · filed 2021-03-30
-$22.81M
derived: sum of 4 quarters · filed 2021-03-30
2018-12-31-$6.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
-$11.70M
derived: sum of 2 quarters · filed 2021-03-30
-$16.05M
derived: sum of 3 quarters · filed 2021-03-30
-$19.46M
10-K · filed 2021-03-30
2018-09-30-$5.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$10.04M
derived: sum of 2 quarters · filed 2019-11-12
-$13.45M
10-Q · filed 2019-11-12
-$15.96M
derived: sum of 4 quarters · filed 2020-03-09
2018-06-30-$4.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
-$7.76M
10-Q · filed 2019-08-13
-$10.27M
derived: sum of 3 quarters · filed 2020-03-09
-$12.71M
derived: sum of 4 quarters · filed 2020-03-09
2018-03-31-$3.41M
10-Q · filed 2019-05-13
-$5.92M
derived: sum of 2 quarters · filed 2020-03-09
-$8.36M
derived: sum of 3 quarters · filed 2020-03-09
2017-12-31-$2.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09
-$4.95M
derived: sum of 2 quarters · filed 2020-03-09
-$9.48M
10-K · filed 2020-03-09
2017-09-30-$2.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$6.97M
10-Q · filed 2018-11-13
2017-06-30-$4.53M
10-Q · filed 2018-08-30
2016-12-31-$5.47M
10-K · filed 2019-03-13